Total Payments
$13,288
2024 Payments
$2,952
Companies
58
Transactions
666
Medicare Patients
17,130
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$13,288 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,288 | 666 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,822 | 91 | $0 (2024) |
| Allergan, Inc. | $885.27 | 41 | $0 (2020) |
| Amgen Inc. | $763.91 | 40 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $731.36 | 28 | $0 (2023) |
| Amarin Pharma Inc. | $658.52 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $592.52 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $559.13 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $551.22 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $460.37 | 19 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $441.76 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,952 | 140 | ABBVIE INC. ($608.17) |
| 2023 | $2,047 | 93 | ABBVIE INC. ($479.16) |
| 2022 | $2,038 | 95 | ABBVIE INC. ($255.93) |
| 2021 | $1,660 | 94 | AbbVie Inc. ($346.11) |
| 2020 | $839.74 | 43 | Amgen Inc. ($131.61) |
| 2019 | $973.61 | 57 | Allergan Inc. ($212.63) |
| 2018 | $1,234 | 69 | Takeda Pharmaceuticals U.S.A., Inc. ($201.17) |
| 2017 | $1,544 | 75 | Allergan Inc. ($445.13) |
All Payment Transactions
666 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.50 | General |
| Category: Hematology/Oncology | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Endocrinology | ||||||
| 11/15/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.73 | General |
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Hematology | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: ANTIBIOTIC | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,983 | 13,966 | $827,732 | $635,382 |
| 2022 | 30 | 3,152 | 16,454 | $1.0M | $769,972 |
| 2021 | 61 | 4,921 | 15,143 | $821,530 | $625,123 |
| 2020 | 81 | 6,074 | 13,459 | $510,714 | $352,751 |
Total Patients
17,130
Total Services
59,022
Medicare Billing
$2.4M
Procedure Codes
203
All Medicare Procedures & Services
203 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 362 | 2,895 | $212,175 | $162,975 | 76.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 515 | 1,772 | $189,439 | $143,109 | 75.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 338 | 2,726 | $156,472 | $121,569 | 77.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 338 | 2,503 | $153,083 | $118,289 | 77.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 144 | 342 | $23,094 | $17,421 | 75.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 128 | $19,284 | $14,276 | 74.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 56 | 208 | $16,316 | $12,749 | 78.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 93 | 93 | $12,520 | $9,183 | 73.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 227 | 573 | $10,019 | $7,613 | 76.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 236 | 686 | $5,880 | $5,757 | 97.9% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 79 | 81 | $5,896 | $4,394 | 74.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 83 | 310 | $5,183 | $4,025 | 77.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,337 | $3,875 | 72.6% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 41 | 121 | $4,756 | $3,515 | 73.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 14 | $1,497 | $1,173 | 78.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,120 | $1,007 | 90.0% |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 2023 | 16 | 457 | $938.80 | $725.78 | 77.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 28 | 29 | $605.12 | $592.95 | 98.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $791.52 | $568.81 | 71.9% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 17 | 29 | $709.63 | $556.51 | 78.4% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 17 | 24 | $568.80 | $445.92 | 78.4% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 23 | 31 | $480.50 | $340.20 | 70.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 14 | $388.64 | $326.50 | 84.0% |
| J7120 | Ringers lactate infusion, up to 1000 cc | Office | 2023 | 38 | 152 | $380.34 | $286.00 | 75.2% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 11 | 20 | $229.20 | $179.80 | 78.4% |
About Dr. Irena Pleskova, MD
Dr. Irena Pleskova, MD is a Hematology & Oncology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639129026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Irena Pleskova, MD has received a total of $13,288 in payments from pharmaceutical and medical device companies, with $2,952 received in 2024. These payments were reported across 666 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($13,288).
As a Medicare-enrolled provider, Pleskova has provided services to 17,130 Medicare beneficiaries, totaling 59,022 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 203 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Brooklyn, NY
- Active Since 05/10/2006
- Last Updated 10/11/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1639129026
Products in Payments
- UBRELVY (Drug) $1,015
- ZENPEP (Drug) $983.46
- Vascepa (Drug) $658.52
- GEMTESA (Drug) $493.24
- XIFAXAN (Drug) $479.48
- VERQUVO (Drug) $420.13
- Linzess (Drug) $410.47
- BREZTRI (Drug) $382.96
- QULIPTA (Drug) $382.33
- LINZESS (Drug) $374.88
- TRELEGY ELLIPTA (Drug) $333.38
- NUZYRA (Drug) $316.61
- ENTRESTO (Drug) $289.46
- Amitiza (Drug) $279.82
- Horizant (Drug) $274.23
- Aimovig (Biological) $262.54
- CREON (Drug) $261.86
- ELIQUIS (Drug) $260.01
- Kerendia (Drug) $255.73
- EVENITY (Biological) $222.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brooklyn
Perry Cook, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Yiwu Huang, Md, MD
Hematology & Oncology — Payments: $268,275
Hematology & Oncology $268,275
Dr. Ilya Blokh, M.d, M.D
Hematology & Oncology — Payments: $191,276
Hematology & Oncology $191,276
Songchuan Guo, M.d, M.D
Hematology & Oncology — Payments: $106,907
Hematology & Oncology $106,907
Yiqing Xu, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $51,145
Hematology & Oncology $51,145
Dr. Azriel Hirschfeld, M.d, M.D
Hematology & Oncology — Payments: $48,699
Hematology & Oncology $48,699